References
- Mix C L. ‘Dumping stomach' following gastrojejunostomy. Surg Clin North Am 1922; 2: 617–22
- Woodward E R. The early postprandial dumping syndrome: clinical manifestations and pathogenesis. Postgastrectomy syndromes, F L Bushkin, E R Woodward. Saunders WB, Philadelphia 1976; 1–13
- Woodward E R, Neustein C L. The late postprandial dumping syndrome. Postgastrectomy syndromes, F L Bushkin, E R Woodward. Saunders WB, Philadelphia 1976; 28–33
- Sawyers J L. Management of postgastrectomy syndromes. Am J Surg 1990; 159: 8–14
- Jenkins D JA, Glassell M A, Leeds A R. Effect of dietary fiber on complications of gastric surgery: prevention of postprandial hypoglycaemia by pectin. Gastroenterology 1977; 72: 215–7
- Hopman W PM, Houben P GMP, Speth P AJ, Lamers C BHW. Glucomannan prevents postprandial hypoglycaemia in patients with previous gastrectomy. Gut 1988; 29: 930–4
- Speth P AJ, Jansen J BMJ, Lamers C BHW. Effect of acarbose, pectin, a combination of acarbose with pectin, and placebo on postprandial reactive hypoglycaemia after gastric surgery. Gut 1983; 24: 789–802
- McMahon M J, Johnston D, Hill G L, Goligher J C. Treatment of severe side effects after vagotomy and gastroenterostomy by closure of gastroenterostomy without pyloroplasty. Br Med J 1978; 1: 7–8
- Cheadle W G, Baker O R, Cushieri A. Pyloric reconstruction for severe vasomotor dumping after vagotomy and pyloroplasty. Ann Surg 1986; 202: 568–72
- Primrose J N. Octreotide in the treatment of the dumping syndrome. Digestion 1990; 1(Suppl 45)49–59
- Santangelo W C, Dueno M I, Pike I, Estes B L, Krejs G J. Clinical efficacy of the somatostatin analogue 201–995 in the postgastrectomy dumping syndrome. Gastroenterology 1987; 92: A1613
- Primrose J N, Johnston D. Somatostatin analogue SMS 201–995 is an effective treatment for the post gastric surgery dumping syndrome provoked by hypertonic glucose. Gastroenterology 1987; 91: 1580
- Hopman W PM, Wolberink R GJ, Lamers C BHW, Van Tongeren J HM. Treatment of the dumping syndrome with the somatostatin analogue SMS 201–995. Ann Surg 1988; 207: 155–9
- Long R G, Adrian T E, Bloom S R. Somatostatin and the dumping syndrome. Br Med J 1985; 290: 886–8
- Primrose J N, Johnston D. Somatostatin analogue SMS 201–995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy. Br J Surg 1989; 76: 140–4
- Geer R J, Richards W O, O'Dorisio T M, Woltering E, Williams S, Rice D, et al. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg 1990; 212: 678–87
- Mackie C R, Jenkins S A, Hartley M N. Treatment of severe postvagotomy/postgastrectomy symptoms with the somatostatin analogue octreotide. Br J Surg 1991; 78: 1338–43
- Lamers C BHW, Bijlstra A M, Harris A G. Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. Dig Dis Sci 1993; 38: 359–64
- Kaushik S P, Ralphs D NL, Hobsley M, Le Quesne L P. Use of a provocation test for objective assessment of dumping syndrome in patients undergoing surgery for duodenal ulcer. Am J Gastroenterol 1980; 74: 251–7
- Linehan I P, Weiman J, Hobsley M. The 15 minute dumping provocation test. Br J Surg 1986; 73: 810–2
- Fenger H J. The dumping disposition in normal persons. Acta Chir Scand 1965; 129: 201–10
- Frederiksen W, Bruusgaard A, Thaysen E H. Assessment of the relationship between gastric secretory capacity and jejunal bacteriology. Scand J Gastroenterol 1973; 8: 353–9
- Browning G G, Buchan K A, Mackay C. The effect of vagotomy and drainage on the small bowel flora. Gut 1974; 15: 139–42